Lv4
413 积分 2021-04-12 加入
First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAFV600E-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort study
1个月前
已完结
PET/CT predict pathological response to neoadjuvant nivolumab in resectable non-small cell lung cancer
1个月前
已完结
Artificial intelligence in drug development
7个月前
已完结
Adjuvant Durvalumab in Completely Resected Early-Stage Non–Small Cell Lung Cancer
8个月前
已完结
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer
8个月前
已完结
Intratumoral Microbiome–related MRI Model for Predicting Breast Cancer Shrinkage Pattern Following Neoadjuvant Therapy
9个月前
已完结
Intratumoral Microbiome–related MRI Model for Predicting Breast Cancer Shrinkage Pattern Following Neoadjuvant Therapy
10个月前
已完结
ITHscore: comprehensive quantification of intra-tumor heterogeneity in NSCLC by multi-scale radiomic features
11个月前
已完结
Intratumoral Microbiome–related MRI Model for Predicting Breast Cancer Shrinkage Pattern Following Neoadjuvant Therapy
11个月前
已完结
Concerns Regarding Sample Size and Credibility of Progression-Free Survival Results—Reply
11个月前
已完结
皖公网安备34019202002308
